In addition, Yu et al. [99] suggested that CD44 promotes angiogenesis in mammary tumor; the mechanism is CD44-associated MMP-9 can activate latent TGF-β by cleaving its TGF-β latency-associated protein, thereby inducing angiogenesis. This evidence concerns the gene CD44 and breast cancer.